Pliant Therapeutics (PLRX) PT Lowered to $43 at Canaccord Genuity
Tweet
Share
E-mailGet Alerts PLRX Hot Sheet
Price: $1.07 -0.93%
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity analyst Edward Nash lowered the price target on Pliant Therapeutics (NASDAQ: PLRX) to $43.00 (from $48.00) while maintaining a Buy rating.
You May Also Be Interested In
- Pliant Therapeutics, Inc. (PLRX) Misses Q2 EPS by 2c
- Zedcor Inc (ZDC:CN) PT Raised to Cdn$7.75 at Desjardins
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
